We aimed here to validate the computational analysis of public scRNA-seq datasets by examination of LOY in CD45 + immune cells from primary tumors, UMs and whole blood as well as in sorted leukocytes isolated from matched peripheral blood of CRC patients. This evidence concerns the gene PTPRC and colorectal carcinoma.